Literature DB >> 12829615

Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes.

Peter A C 't Hoen1, Christian A C Van der Lans, Miranda Van Eck, Martin K Bijsterbosch, Theo J C Van Berkel, Jaap Twisk.   

Abstract

Oxidative stress has been implicated in the development of atherosclerotic lesions. We evaluated the relationship between extent of atherosclerotic lesion formation and vascular expression of pro- and antioxidant enzymes in apoE-deficient mice. On normal chow, these mice showed elevated serum cholesterol levels (7.5- to 9.5-fold), and age-dependent, spontaneous development of all stages of atherosclerotic lesions, starting at the age of 12 weeks. RNA was extracted from the aortic arch and descending aorta, and mRNA expression of pro- and antioxidant enzymes was measured with real-time PCR. Local infiltration of monocytes/macrophages, reflected by increased vascular expression of CD68 mRNA (>10-fold), indicated that the arch was more susceptible than the descending aorta. The expression of catalase-1 and various isoforms of superoxide dismutase, glutathione peroxidase, and glutathione S-transferase alpha was significantly increased in the aortic arch, but not in the descending aorta, in the period preceding lesion formation (age 6 to 12 weeks). These expression levels were 1.5 to 5 times higher than in age-matched wild-type animals. Remarkably, there was an inverse relationship between extent of lesion formation and the mRNA levels of antioxidant enzymes, most of which started to decline after 12 weeks, as lesions developed. In contrast, inducible nitric oxide synthase expression increased 4-fold in the aortic arch over the course of the disease. Our results suggest that the arterial wall responds to increased serum levels of atherogenic lipoproteins by stimulating expression of antioxidant enzymes. The observed co-ordinate decline in expression of many of these protective systems may greatly accelerate the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829615     DOI: 10.1161/01.RES.0000082978.92494.B1

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  24 in total

1.  IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype.

Authors:  Jan H von der Thüsen; Keren S Borensztajn; Silvia Moimas; Sandra van Heiningen; Peter Teeling; Theo J C van Berkel; Erik A L Biessen
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Genetic reduction of lipoic acid synthase expression modestly increases atherosclerosis in male, but not in female, apolipoprotein E-deficient mice.

Authors:  Xianwen Yi; Longquan Xu; Kuikwon Kim; Hyung-Suk Kim; Nobuyo Maeda
Journal:  Atherosclerosis       Date:  2010-03-10       Impact factor: 5.162

3.  Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation.

Authors:  Martine Bot; Ilze Bot; Rubén Lopez-Vales; Chris H A van de Lest; Jean Sébastien Saulnier-Blache; J Bernd Helms; Samuel David; Theo J C van Berkel; Erik A L Biessen
Journal:  Am J Pathol       Date:  2010-04-29       Impact factor: 4.307

4.  Gain and loss of function for glutathione synthesis: impact on advanced atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Andrea Callegari; Yuhua Liu; Collin C White; Alan Chait; Peter Gough; Elaine W Raines; David Cox; Terrance J Kavanagh; Michael E Rosenfeld
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

5.  Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice.

Authors:  J Stegbauer; S A Potthoff; I Quack; E Mergia; T Clasen; S Friedrich; O Vonend; M Woznowski; E Königshausen; L Sellin; L C Rump
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

6.  CXCR4 blockade induces atherosclerosis by affecting neutrophil function.

Authors:  Ilze Bot; Isabelle T M N Daissormont; Alma Zernecke; Gijs H M van Puijvelde; Birgit Kramp; Saskia C A de Jager; Judith C Sluimer; Marco Manca; Veronica Hérias; Marijke M Westra; Martine Bot; Peter J van Santbrink; Theo J C van Berkel; Lishan Su; Mona Skjelland; Lars Gullestad; Johan Kuiper; Bente Halvorsen; Paul Aukrust; Rory R Koenen; Christian Weber; Erik A L Biessen
Journal:  J Mol Cell Cardiol       Date:  2014-05-08       Impact factor: 5.000

7.  Nitric oxide regulates vascular adaptive mitochondrial dynamics.

Authors:  Matthew W Miller; Leslie A Knaub; Luis F Olivera-Fragoso; Amy C Keller; Vivek Balasubramaniam; Peter A Watson; Jane E B Reusch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

8.  Glutathione peroxidase-1 plays a major role in protecting against angiotensin II-induced vascular dysfunction.

Authors:  Sophocles Chrissobolis; Sean P Didion; Dale A Kinzenbaw; Laura I Schrader; Sanjana Dayal; Steven R Lentz; Frank M Faraci
Journal:  Hypertension       Date:  2008-02-25       Impact factor: 10.190

Review 9.  NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology.

Authors:  Randall S Frey; Masuko Ushio-Fukai; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

10.  Endothelial function in aorta segments of apolipoprotein E-deficient mice before development of atherosclerotic lesions.

Authors:  Paul Fransen; Tim Van Assche; Pieter-Jan Guns; Cor E Van Hove; Gilles W De Keulenaer; Arnold G Herman; Hidde Bult
Journal:  Pflugers Arch       Date:  2007-09-27       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.